MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...

Objective Phase II trials suggest glucagon-like peptide-1 receptor (GLP1) agonists resolve metabolic dysfunction-associated steatohepatitis but do not affect fibrosis regression. We aimed to determine ...

Boehringer Ingelheim recently announced the start of the THULITE phase II clinical study ( NCT06962839 ). THULITE will ...

A handful of people are being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS.

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Defenders of Medicaid cuts point to the Oregon Health Insurance Experiment to argue that the cuts won’t harm people’s health.

Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...

Insulin-producing human pancreas cells can be manufactured with 3D printers, researchers reported at the International Transplant Congress underway in London.

Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving ...

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...